Sponsor pipeline

Avalyn Pharma Inc. clinical trial pipeline

Get alerts when Avalyn Pharma Inc.'s trials change

3 active trials 2 recruiting 3 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06951217 An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) Progressive Pulmonary Fibrosis Recruiting 2026-10-02
NCT07194382 AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02… Idiopathic Pulmonary Fibrosis (IPF) Recruiting 2026-08-10
NCT06329401 A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With… Pulmonary Fibrosis Active, Not Recruiting 2026-10-05

Disease areas by active trials

Idiopathic Pulmonary Fibrosis (2) · Rheumatoid Arthritis (1) · Scleroderma (1)

Get alerts when Avalyn Pharma Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free